BIOMAT Database Logo BIOMAT Database Logo

Detection and quantification of multiple drug resistance mutations in HIV-1 reverse transcriptase by an oligonucleotide ligation assay. 2001

M L Villahermosa, and I Beck, and L Pérez-Alvarez, and G Contreras, and L M Frenkel, and S Osmanov, and E V de Parga, and E Delgado, and N Manjon, and M T Cuevas, and M M Thomson, and L Medrano, and R Najera
Centro Nacional Biologia Fundamental, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain. rafael.najera@isciii.es

OBJECTIVE To develop an assay for the early detection and quantification of minor human immunodeficiency virus-1 populations bearing multiple drug resistance (MDR) mutations. METHODS The oligonucleotide ligation assay (OLA) is based on ligation of probe and detector oligonucleotides annealed to a polymerase chain reaction amplicon strand with detection by an enzyme immunoassay. In OLA-MDR, oligonucleotides were designed to detect MDR mutations. The method was validated with wild-type and MDR mutant clones mixed at different proportions. RESULTS K103N mutants were detected as minor populations (5%-30%) by OLA in 6 of 18 samples from patients treated with nonnucleoside reverse transcription inhibitors and classified as wild type by sequencing. In one patient, the kinetics of the increase of MDR mutants could be followed in sequential samples, with K103N being detected earlier by OLA than by sequencing. Q151M mutants were detected as minor populations (13%-24%) by OLA but not by sequencing in 4 samples. CONCLUSIONS Oligonucleotide ligation assay MDR exhibits higher sensitivity than sequencing for detection of minor MDR mutant populations.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009838 Oligodeoxyribonucleotides A group of deoxyribonucleotides (up to 12) in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties. Oligodeoxynucleotide,Oligodeoxyribonucleotide,Oligodeoxynucleotides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015345 Oligonucleotide Probes Synthetic or natural oligonucleotides used in hybridization studies in order to identify and study specific nucleic acid fragments, e.g., DNA segments near or within a specific gene locus or gene. The probe hybridizes with a specific mRNA, if present. Conventional techniques used for testing for the hybridization product include dot blot assays, Southern blot assays, and DNA:RNA hybrid-specific antibody tests. Conventional labels for the probe include the radioisotope labels 32P and 125I and the chemical label biotin. Oligodeoxyribonucleotide Probes,Oligonucleotide Probe,Oligoribonucleotide Probes,Probe, Oligonucleotide,Probes, Oligodeoxyribonucleotide,Probes, Oligonucleotide,Probes, Oligoribonucleotide
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D024921 Drug Resistance, Multiple, Viral The ability of viruses to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance phenotype may be attributed to multiple gene mutation. Drug Resistance, Extensive, Viral,Drug Resistance, Extensively, Viral,Extensive Antiviral Drug Resistance,Extensively Antiviral Drug Resistance,Multidrug Resistance, Viral,Multiple Antiviral Drug Resistance,Resistance, Viral Multidrug,Viral Multidrug Resistance,Viral Multidrug Resistances

Related Publications

M L Villahermosa, and I Beck, and L Pérez-Alvarez, and G Contreras, and L M Frenkel, and S Osmanov, and E V de Parga, and E Delgado, and N Manjon, and M T Cuevas, and M M Thomson, and L Medrano, and R Najera
Evaluation of an oligonucleotide ligation assay for detection of mutations in HIV-1 subtype C individuals who have high level resistance to nucleoside reverse transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors.
May 2005, Journal of virological methods,
M L Villahermosa, and I Beck, and L Pérez-Alvarez, and G Contreras, and L M Frenkel, and S Osmanov, and E V de Parga, and E Delgado, and N Manjon, and M T Cuevas, and M M Thomson, and L Medrano, and R Najera
Paper-based detection of HIV-1 drug resistance using isothermal amplification and an oligonucleotide ligation assay.
March 2018, Analytical biochemistry,
M L Villahermosa, and I Beck, and L Pérez-Alvarez, and G Contreras, and L M Frenkel, and S Osmanov, and E V de Parga, and E Delgado, and N Manjon, and M T Cuevas, and M M Thomson, and L Medrano, and R Najera
Identification of insertion mutations in HIV-1 reverse transcriptase causing multiple drug resistance to nucleoside analogue reverse transcriptase inhibitors.
January 1999, Journal of human virology,
M L Villahermosa, and I Beck, and L Pérez-Alvarez, and G Contreras, and L M Frenkel, and S Osmanov, and E V de Parga, and E Delgado, and N Manjon, and M T Cuevas, and M M Thomson, and L Medrano, and R Najera
HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.
January 2007, AIDS (London, England),
M L Villahermosa, and I Beck, and L Pérez-Alvarez, and G Contreras, and L M Frenkel, and S Osmanov, and E V de Parga, and E Delgado, and N Manjon, and M T Cuevas, and M M Thomson, and L Medrano, and R Najera
Nucleoside drug resistance in HIV-1 reverse transcriptase.
March 1995, Nature structural biology,
M L Villahermosa, and I Beck, and L Pérez-Alvarez, and G Contreras, and L M Frenkel, and S Osmanov, and E V de Parga, and E Delgado, and N Manjon, and M T Cuevas, and M M Thomson, and L Medrano, and R Najera
Reverse transcriptase inhibitors drug resistance mutations in drug-naive HIV type 1 positive Kenyans.
January 2011, East African medical journal,
M L Villahermosa, and I Beck, and L Pérez-Alvarez, and G Contreras, and L M Frenkel, and S Osmanov, and E V de Parga, and E Delgado, and N Manjon, and M T Cuevas, and M M Thomson, and L Medrano, and R Najera
APOBEC3G versus reverse transcriptase in the generation of HIV-1 drug-resistance mutations.
September 2004, AIDS (London, England),
M L Villahermosa, and I Beck, and L Pérez-Alvarez, and G Contreras, and L M Frenkel, and S Osmanov, and E V de Parga, and E Delgado, and N Manjon, and M T Cuevas, and M M Thomson, and L Medrano, and R Najera
Detection of low-frequency HIV type 1 reverse transcriptase drug resistance mutations by ultradeep sequencing in naive HIV type 1-infected individuals.
February 2014, AIDS research and human retroviruses,
M L Villahermosa, and I Beck, and L Pérez-Alvarez, and G Contreras, and L M Frenkel, and S Osmanov, and E V de Parga, and E Delgado, and N Manjon, and M T Cuevas, and M M Thomson, and L Medrano, and R Najera
HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals.
January 2020, PloS one,
M L Villahermosa, and I Beck, and L Pérez-Alvarez, and G Contreras, and L M Frenkel, and S Osmanov, and E V de Parga, and E Delgado, and N Manjon, and M T Cuevas, and M M Thomson, and L Medrano, and R Najera
Mutations conferring drug resistance affect eukaryotic expression of HIV type 1 reverse transcriptase.
February 2004, AIDS research and human retroviruses,
Copied contents to your clipboard!